Inospiron 25 mg is primarily indicated for conditions associated with fluid retention, hypertension, and potassium imbalance. Its main indications include:
Congestive Heart Failure (CHF):
Helps reduce edema and fluid overload in patients with heart failure.
Hepatic Cirrhosis with Ascites and Edema:
Assists in managing fluid accumulation in liver disease patients.
Nephrotic Syndrome:
Reduces swelling caused by kidney disorders.
Primary Hyperaldosteronism:
Used pre-operatively or as long-term therapy in patients with excess aldosterone production.
Essential Hypertension:
Lowers blood pressure by promoting sodium and water excretion while retaining potassium.
Hypokalemia (Low Potassium):
Corrects potassium deficiency caused by other diuretics.
Potassium-Sparing Diuretics
Aldosterone Antagonists
Inospiron 25 mg is a selective aldosterone antagonist. It works by binding competitively to mineralocorticoid receptors in the distal convoluted renal tubule, which blocks the effects of aldosterone.
Mechanism:
Sodium & Water Excretion: Prevents sodium reabsorption, promoting diuresis.
Potassium Retention: Limits potassium excretion, helping maintain electrolyte balance.
Blood Pressure Reduction: By reducing fluid volume and vascular resistance.
May be used alone or in combination with other diuretics that act on more proximal parts of the nephron.
Edema (CHF, cirrhosis, nephrotic syndrome):
Initial: 100 mg daily (single or divided doses)
Range: 25–200 mg daily
Primary Hyperaldosteronism:
100–400 mg daily, depending on pre- or post-surgery requirements
Essential Hypertension:
50–100 mg daily
Hypokalemia:
25–100 mg daily
Notes: Doses should be individualized based on patient response and condition.
ACE Inhibitors: May increase risk of hyperkalemia
Lithium: Risk of toxicity due to decreased renal clearance
Digoxin: Can increase digoxin half-life
Alcohol, Barbiturates, Narcotics: May potentiate orthostatic hypotension
Corticosteroids, ACTH: Can worsen electrolyte imbalance
Acute renal insufficiency or significant renal impairment
Anuria
Hyperkalemia
Hypersensitivity to Inospiron 25 mg
Endocrine: Gynecomastia, irregular menses, post-menopausal bleeding
Gastrointestinal: Cramping, diarrhea
Neurological: Drowsiness, lethargy, headache, mental confusion
Others: Impotence, urticaria
Pregnancy: Not recommended
Lactation: Canrenone, an active metabolite, appears in breast milk; consider alternative feeding methods if necessary
Monitor electrolytes, particularly potassium
Risk of hyperkalemia in patients with impaired renal function or high potassium intake
Watch for signs of fluid imbalance
Symptoms: Drowsiness, dizziness, mental confusion, diarrhea, vomiting
Management: Gastric lavage, supportive treatment, monitoring electrolytes
Store in a cool, dry place, protected from light
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet